GLENMEDE TRUST CO NA: AAXJ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GLENMEDE TRUST CO NA on AAXJ, newest first. How the timeline and the estimate are built.
GLENMEDE TRUST CO NA held 8,243 AAXJ shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 8,243 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $983,637.
13F-HR 0001398344-26-013895 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 8,243 sharesChange vs previous 13F +422 shares
<0.01% of the 13F portfolio, value $793,718.
13F-HR 0001398344-26-009724 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 7,821 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $728,291.
13F-HR 0001398344-26-003230 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 7,821 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $578,754.
13F-HR 0001398344-25-009609 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 7,821 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $564,519.
13F-HR 0001398344-25-002875 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 7,821 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $613,557.
13F-HR 0001398344-24-020665 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).